SDH of HPV Vaccine Completion

Completed

Conditions studied: Human Papilloma Virus

In brief

The purpose of this research study is to find out which factors influence parents' ability to complete the human papillomavirus (HPV) vaccine series for their child. The information learned from this study may help the investigators develop programs to improve HPV vaccine completion rates among adolescents and reduce barriers to receiving the second shot of the vaccine series.

Key facts

Study ID

NCT03709602

Run by

Duke University

People needed

3076

Starts

2019-01-07

Expected to finish

2019-12-17

Last updated by the study team

2020-09-01

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• For adolescents, participants need to be between the ages 11 to 14 years.
• Received 1 dose of the HPV vaccine series between January 2017 and December 2017.
• For parents, there is no age limit required.
• Parents as defined as the adolescent's biological mother or father, step-parents, or legal guardian.
• Parents or legal guardians who self-identified as the primary caregiver of the adolescent child and most likely to make medical decisions for the adolescent.

You may not qualify if…

• Parents with cognitive impairment.
• Adolescents with cognitive impairment.
• Adolescents emancipated from their parents or legal guardian
• Pregnant adolescent girls.

Where it is running

• Duke University Primary Care Pediatrics at Roxboro Road — Durham, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.